Outcome of the ‘Drip-and-Ship’ Paradigm among Patients with Acute Ischemic Stroke: Results of a Statewide Study
Background: The ‘drip-and-ship’ paradigm denotes a treatment regimen in patients in whom intravenous (IV) recombinant tissue plasminogen activator (rt-PA) is initiated at the emergency department (ED) of a community hospital, followed by transfer within 24 h to a comprehensive stroke center. Althoug...
Main Authors: | Adnan I. Qureshi, Saqib A. Chaudhry, Gustavo J. Rodriguez, M. Fareed K. Suri, Kamakshi Lakshminarayan, Mustapha A. Ezzeddine |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-01-01
|
Series: | Cerebrovascular Diseases Extra |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/335097 |
Similar Items
-
Modeling the Impact of Prehospital Triage on a True-Life Drip and Ship Mechanical Thrombectomy Urban Patient Cohort
by: Stavros Matsoukas, et al.
Published: (2021-11-01) -
Outcomes of thrombolytic therapy in acute ischemic stroke: mothership, drip-and-ship, and ship-and-drip paradigms
by: Naruchorn Kijpaisalratana, et al.
Published: (2020-02-01) -
Clinical outcome, recanalization success, and time metrics in drip-and-ship vs. drive-the-doctor: A retrospective analysis of the HEI-LU-Stroke registry
by: Christian Urbanek, et al.
Published: (2023-03-01) -
Intravenous Thrombolysis for Embolic Stroke due to Cardiac Myxoma
by: Mu-Chien Sun, et al.
Published: (2011-01-01) -
Liquid Chromatography Fingerprint Analysis of Released Compounds in Plasma Samples of Stroke Patients after Thrombolytic Treatment
by: Mar Castellanos, et al.
Published: (2023-01-01)